ВЛИЯНИЕ ХИМИОИНДУЦИРОВАННОЙ ПОЛИНЕЙРОПАТИИ НА КАЧЕСТВО ЖИЗНИ И ПОВСЕДНЕВНУЮ АКТИВНОСТЬ У БОЛЬНЫХ С РАКОМ ЯИЧНИКОВ

Авторы

  • Ҳайдаров Нодир Қадирович
  • Хайдаров Нодир Кадирович
  • Раимова Малика Мухамеджановна

Ключевые слова:

химиоиндуцированная полинейропатия, химиотерапия, рак яичников, качество жизни, нейротоксичность

Аннотация

The article provides data on the study of the effect of chemo-induced polyneuropathy (HIPN) on the daily activity and quality of life of patients with ovarian cancer, as well as evaluating the effectiveness of the use of antioxidants and nucleotides in combination with antitumor drugs to reduce the severity of HIPN and improve the quality of life of patients. The patients were divided into two groups: group A (n=40) received chemotherapy with taxanes and/or platinum compounds combined with antioxidants and nucleotides, while group B (n=30) received standard treatment. The assessment of HIPN symptoms and quality of life was carried out using the FACT/GOG-Ntx and EORTC QLQ-CIPN20 questionnaires. In group A, there was a significant improvement on the FACT/GOG-Ntx scale, especially in reducing sensory, motor and autonomic symptoms after three cycles of chemotherapy. In group B, improvements were less pronounced, and some patients reported worsening symptoms. Statistical analysis showed a significant decrease in the severity of symptoms in group A (p<0.05), while changes in group B were not statistically significant (p>0.05).

Библиографические ссылки

Anoushirvani AA, Poorsaadat L, Aghabozorgi R, Kasravi M. Comparison of the Effects of Omega 3 and Vitamin E on Palcitaxel-Induced Peripheral Neuropathy. Open Access Macedonian J Med Sci (2018) 62018:1857–61.

Bakitas MA. Background noise: the experience of chemotherapy-induced peripheral neuropathy. Nurs Res. 2007;56:323–331.

Banach M, Juranek JK, Zygulska AL. Chemotherapy-induced neuropathies-a growing problem for patients and health care providers. Brain Behav. 2017;7

Beijers AJM, Bonhof CS, Mols F, Ophorst J, de Vos-Geelen J, Jacobs EMG, et al.. Multicenter Randomized Controlled Trial to Evaluate the Efficacy and Tolerability of Frozen Gloves for the Prevention of Chemotherapy-Induced Peripheral Neuropathy. Ann Oncol (2020) 31(1):131–6.

Brewer JR, Morrison G, Dolan ME, Fleming GF. Chemotherapy-induced peripheral neuropathy: Current status and progress. Gynecol Oncol. 2016;140:176–183.

Cioroiu C, Weimer LH. Update on chemotherapy-induced peripheral neuropathy. Curr Neurol Neurosci Rep. 2017; 17(6):47.

Cavaletti G, Marmiroli P. Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity. Expert Opin Pharmacother. 2018;19:113–121.

Ezendam NP, Pijlman B, Bhugwandass C, Pruijt JF, Mols F, Vos MC, Pijnenborg JM, van de Poll-Franse LV. Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: results from the population-based PROFILES registry. Gynecol Oncol. 2014;135:510–517.

Glare PA, Davies PS, Finlay E, Gulati A, Lemanne D, Moryl N, Oeffinger KC, Paice JA, Stubblefield MD, Syrjala KL. Pain in cancer survivors. J Clin Oncol. 2014;32:1739–1747.

Hershman DL, Unger JM, Crew KD, Till C, Greenlee H, Minasian LM, et al.. Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715). J Natl Cancer Inst (2018) 110(6):669–76.

Kanbayashi Y, Sakaguchi K, Ishikawa T, Ouchi Y, Nakatsukasa K, Tabuchi Y, et al.. Comparison of the Efficacy of Cryotherapy and Compression Therapy for Preventing Nanoparticle Albumin-Bound Paclitaxel-Induced Peripheral Neuropathy: A Prospective Self-Controlled Trial. Breast (2020) 49:219–24.

Khalefa HG, Shawki MA, Aboelhassan R, El Wakeel LM. Evaluation of the Effect of N-Acetylcysteine on the Prevention and Amelioration of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Randomized Controlled Study. Breast Cancer Res Treat (2020) 183(1):117–25.

Kotani H, Terada M, Mori M, Horisawa N, Sugino K, Kataoka A, et al.. Compression Therapy Using Surgical Gloves Does Not Prevent Paclitaxel-Induced Peripheral Neuropathy: Results From a Double-Blind Phase 2 Trial. BMC Cancer (2021) 21(1):548.

Mols F, Beijers T, Vreugdenhil G, van de Poll-Franse L. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer. 2014;22:2261–2269.

Staff NP, Grisold A, Grisold W, Windebank AJ. Chemotherapy-induced peripheral neuropathy: A current review. Ann Neurol. 2017;81:772–781.

Tofthagen C. Surviving chemotherapy for colon cancer and living with the consequences. J Palliat Med. 2010;13:1389–1391.

Wu S, Bai X, Guo C, Huang Z, Ouyang H, Huang J, Zeng W. Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis. BMC Cancer. 2021 Nov 2;21(1):1173.

Zis P, Varrassi G, Vadalouka A, Paladini A. Psychological Aspects and Quality of Life in Chronic Pain. Pain Res Manag. 2019;2019:8346161.

Загрузки

Опубликован

2024-09-26